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INTRODUCTION
Interactions of nanoparticles with their in vivo environment is an important factor and affects nanoparticle characteristics such as protein binding, toxicity, pharmacokinetics, and biodistribution [1] [2] [3] [4] [5] [6] [7] [8] . Accumulation of nanoparticles in healthy organs, such as the liver, kidneys, spleen, and lungs can lead to toxicity and lower efficacy of the administered dose of nanoparticles.
While researchers are attempting to overcome this challenge with myriad of different nanoparticle systems, generally, less than 2% of the administered dose reaches the treatment site with the remaining dose sequestered by filtration organs, which leads to toxicity and off-target drug effects 4 .
Recently, RNA nanoparticles have seen increased use as an in vivo delivery system [9] [10] [11] [12] [13] [14] [15] [16] .
Additionally, RNA based nanoparticles have been engineered to diverse shapes and sizes to carry multiple functionalities with unique release mechanisms [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] . RNA was once thought to have little potential for in vivo use due to biological and thermodynamic stability issues. However, these issues have been solved systematically by: (1) Finding of a thermodynamically stable three-way junction (3WJ) motif 9 ; (2) Findings that chemical modifications to RNA nanoparticles confer enzymatic stability in vivo [31] [32] [33] [34] ; and (3) Finding that RNA nanoparticles exhibit little to no immunogenicity in vivo 19 . RNA nanoparticles are also water soluble and anionic due to the charged phosphate backbone. RNA nanoparticles show no accumulation in healthy organs, navigating to tumors after four hours of circulation [9] [10] [11] [12] [35] [36] [37] [38] .
It is well known that a nanoparticle's size, shape, and physical properties affects their interactions and biodistribution in vivo, and will therefore play a large role in determining their pharmacokinetics and biodistribution 2, 39, 40 . Thus, tremendous efforts have been made by nanoparticle engineers to overcome inherent downfalls in nanoparticle construction. For example, polyethylene glycol (PEG) is frequently used to increase water solubility of otherwise insoluble nanoparticles 41, 42 .
Conjugation of chemicals, such as fluorophores, drugs, and targeting ligands, is a popular method to decorate nanoparticles with functional moieties. However, many studies using hydrophobic fluorophores show nanoparticle accumulation in vital organs such as the liver, kidneys, lung, and spleen [43] [44] [45] [46] [47] . It is possible that the hydrophobic conjugates, in this case fluorophores, are promoting interaction with cell membranes and plasma proteins, causing
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accumulation of the nanoparticles in organs. In order for a nanoparticle to display low toxicity and low accumulation in vital organs, it is important to understand how conjugation of chemicals to nanoparticles affects their in vivo properties.
Previous in vivo studies using pRNA nanoparticles were carried out using charged and water soluble fluorophores to make sure the properties of the nanoparticles were not changed drastically [9] [10] [11] 48 . However, as RNA nanotechnology progresses it will be important to know to what extent an RNA nanoparticle can be decreased in water solubility before accumulating in vital organs. Many potential applications such as chemical drug delivery and ligand based targeting involve conjugation of chemical groups to RNA nanoparticles, and many near-infrared fluorophores are hydrophobic potentially causing organ accumulation [43] [44] [45] [46] [47] . Additionally, toxicity and lower therapeutic effect of certain drugs, such as Taxol, has been correlated to their insolubility. When chemicals are conjugated externally and not encapsulated, the impact of the conjugate is likely to be more significant.
To investigate this, three fluorophores of different hydrophobicities were conjugated to the 3WJ RNA nanoparticle to serve as model chemicals: Cyanine5.5 (C5.5); Sulfonated-Cyanine 5.5 (SC5.5); and AlexaFluor700 (A700). All three fluorophores display similar excitation and emission spectra, despite minimal differences in their structures and solubility 49, 50 . This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
MATERIALS AND METHODS

RNA Synthesis and Fluorophore Conjugation
RNA oligomers were chemically synthesized using typical phosphoramidite chemical synthesis on an automated oligo synthesizer. Sequences of the RNA oligomers used in biodistribution studies are as follows, listed in 5' to 3' orientation ("r" denotes 2'-OH base, "f" This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
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Determination of Predictive ClogP Values
ChemDraw Professional 16 was used to predict ClogP values of amino acids, fluorophores, and nucleotide-fluorophore conjugates. Amino acids, fluorophores, and nucleotide-fluorophore conjugates were drawn with charges analogous to their charged state at physiological pH = 7.4.
Only the side chains of the amino acids were used for predictive ClogP calculations. Predicted
ClogP values of amino acid side chains were then plotted versus previously published hydrophobicity scales of amino acids 53, 54, 56, 57 . Four different hydrophobicity scales were chosen for comparison ( Supp Fig 2) and it was found that the Cornette hydrophobicity scale was the best match to predictive ClogP values. The Cornette scale is based on 28 published scales and demonstrates one of the best overall scales of amino acid hydrophobicity. High values indicate higher degree of hydrophobicity.
Next, ClogP values of C5.5, SC5.5, and mono, di, and trinucleotide derivatives of the fluorophores were predicted (Supp Table 2 ). The structure of A700 is proprietary, and no structural information was available, however, SC5.5 and A700 demonstrate similar hydrophobicity based on IPRP-HPLC.
Human Gene Therapy
This article has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
The Hydrophobic Effect from Conjugated Chemicals or Drugs on in Vivo Biodistribution of RNA Nanoparticles (DOI: 10.1089/hum.2017.054)
This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
In vivo Biodistribution
Male BALB/c mice, 5-6 weeks old, (Taconic) were injected intravenously (IV) through the eye using retro-orbital injection 58 . 
Atomic Force Microscopy Imaging
Specially modified mica surfaces (APS mica) were used. The APS mica was obtained by incubation of freshly cleaved mica in 167nM 1-(3-aminopropyl) silatrane following previously reported protocol 59 . The RNA samples were diluted with 1 × TMS buffer to a final concentration of 3 -5 nM. Then, 5-10 µL was immediately deposited on APS mica. After 2min incubation on the surface, excess samples were washed with DEPC treated water and dried under a flow of Argon gas. AFM images in air were acquired using MultiMode AFM NanoScope IV system (Veeco/Digital Instruments, Santa Barbara, CA) operating in tapping mode. The 3WJ nanoparticles used for AFM imaging only included 60 base pair extensions in order to better visualize the nanoparticles. Please refer to sequence information listed in the RNA Synthesis methods section for sequence information of RNA nanoparticles used in biodistribution studies.
RESULTS AND DISCUSSION
3WJ-fluorophore HPLC analysis
The 3WJ is composed of three component RNA oligomers: 3WJ-a, 3WJ-b, and 3WJ-c ( Fig   1A) . Mixing equimolar amounts of each component strand at room temperature in physiological buffer yields homogeneous RNA nanoparticles (Fig 1B) 9 . To fluorescently label the 3WJ
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nanoparticles, NHS-Ester derivatives of C5.5, SC5.5, and A700 were conjugated to primary amine labeled 3WJ-c strand (Fig 1C) . Fluorophore conjugated oligomers were purified from un-labeled RNA by IPRP-HPLC. Following assembly of fluorophore labeled 3WJ nanoparticles (3WJ-C5.5, 3WJ-SC5.5, 3WJ-A700), polyacrylamide (PAGE) gel analysis was used to determine assembly efficiency.
A decrease in migration rate of fully assembled 3WJ nanoparticles compared to monomer and dimer species indicates successful formation at high yield (Fig 2A) . Gels were stained with ethidium bromide (EB) for total RNA visualization followed by scanning for EB and fluorophore signal. Comigration of EB and fluorophore signal indicates successful incorporation of fluorophore-labeled oligomers into 3WJ nanoparticles. Labeling only one of three strands was used to confirm that the particles were not dissociating in vivo. It has been shown previously that single stranded RNA is eliminated rapidly through the kidneys after intravenous (IV) injection 60, 61 .
3WJ particles were then analyzed by IPRP-HPLC to compare elution times and %ACN elution (Fig 2B) . Supplemental Table 1 shows a summary of nanoparticle elution times and %ACN elution. There is a strong correlation between the number of charged sulfate groups per fluorophore and the %ACN elution. 3WJ-C5.5 has the highest %ACN elution of 46.39 followed by 3WJ-SC5.5 at 22.72% and finally 3WJ-A700 at 21.49%. 3WJ with no fluorophore eluted at 14.13
%ACN. HPLC analysis indicates that different chemicals conjugated to RNA nanoparticles will increase the nanoparticle's hydrophobicity to differing degrees.
RNA nanoparticles solubilize hydrophobic chemicals
The hydrophilic property of RNA nanoparticles enables them to solubilize many hydrophobic chemicals. IPRP-HPLC demonstrates an increase in solubility (decrease in %ACN elution) from fluorophore alone to 3WJ-c-fluorophore to 3WJ-fluorophore ( Supp Fig 1B-D) .
Interestingly, we see a much larger decrease in %ACN elution for the hydrophobic Cy5.5 fluorophore than for both hydrophilic fluorophores, indicated by more negative slope for Cy5.5 (Fig   3) . The effect of RNA nanoparticles increasing solubility is evidenced by decreased fluorescent signal in vital organs when comparing 3WJ-fluorophore to fluorophore alone (Fig 4B) . Especially strong evidence supporting this fact is observed when comparing fluorescence in lung and liver tissue between mice injected with fluorophore alone and 3WJ-fluorophore nanoparticles (Fig 5) .
The fluorophores alone accumulate in vital organs after 4 h whereas 3WJ-fluorophores display lower fluorescence, especially with C5.5 and A700.
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However, despite the high overall hydrophilicity, we still see both increased %ACN elution and accumulation with hydrophobic cell membranes when using a hydrophobic conjugate. This once again leads us to believe that the conjugate itself is interacting with cell membranes, and if the interaction of the conjugate with the cell membrane is strong enough it can overcome the hydrophilic nature of the RNA nanoparticle and the anionic property of RNA. Thus, not only is the overall hydrophilicity of the nanoparticle important, but so are the specific surface properties of the nanoparticle.
Fluorophore hydrophobicity vs biodistribution
Following HPLC analysis, the fluorophores were injected retro-orbitally into mice and fluorescent signal was whole body imaged 1, 4, and 8 h post-injection. Mice were then sacrificed and their organs collected and imaged. Fluorescent imaging from whole body images show low signal for A700 and SC5.5 and higher signal for C5.5 (Fig 4A) . Organ images of the mice injected with the fluorophores all show fluorescent signal after 8 h (Fig 4B) . These observations correlate well with the increased hydrophobicity of C5.5 over both SC5.5 and A700.
3WJ-fluorophore hydrophobicity vs biodistribution
The in vivo properties of the 3WJ-fluorophore nanoparticles were analyzed by testing their biodistribution profiles in mice. Whole body images indicate faster clearance of 3WJ-SC5.5 and 3WJ-A700 compared to and 3WJ-C5.5 (Fig 4) . 3WJ-C5.5 showed high fluorescent signal in the organs compared to mice injected with PBS as a blank, primarily accumulating in the liver and kidneys after 8 h (Fig 4B) . 3WJ-SC5.5 does show fluorescence in organs after 8 h, albeit much less intense than observed for 3WJ-C5.5. 3WJ-A700 shows no fluorescence in organs after 8 h. These in vivo results demonstrate a strong correlation between the increased hydrophobicity of the fluorophore and increased accumulation of nanoparticles in organs. Furthermore, these results
show the ability of the 3WJ nanoparticle to increase the solubility of the fluorophores as less accumulation in vital organs of 3WJ-fluor nanoparticles is seen when compared to fluorophores. This is evidenced when examining differences in lung and liver tissue between mice injected with fluors alone and with 3WJ-fluorophore (Fig 5) .
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Physical basis for hydrophobicity effect on biodistribution
After in vivo results, we sought a physical explanation for our observations. One likely explanation for accumulation of the nanoparticles is interaction with proteins and cell membranes in vivo. It is our hypothesis that the increased hydrophobicity of the fluorophores conjugated to the 3WJ nanoparticles initiates interaction with the hydrophobic regions of proteins and cell membranes, causing the nanoparticles to accumulate in organs. Many studies have been done on the hydrophobicity of proteins and how the amino acid arrangement creates pockets of hydrophobicity and hydrophilicity [51] [52] [53] [54] 56, 57 . These studies have generated amino acid hydrophobicity scales, which are used to predict hydrophobic regions in proteins and determine trans-membrane protein regions.
We hypothesized that the increased hydrophobicity of 3WJ-C5.5 was increasing the strength of the interactions between the hydrophobic regions of proteins and cell membranes and the nanoparticles. Because the RNA nanoparticles are extremely hydrophilic with a hydrophobic fluorophore attached, we expect them to exhibit an amphipathic property. This is akin to transmembrane proteins, which are amphipathic to cross cell membranes.
A logP (partition coefficient) value is the ratio of a compounds solubility in two immiscible solvents, normally octanol: water, and is a good indication of hydrophobicity. (Fig 6A) . A dotted line represents a neutral value of 0. The ClogP values were then plotted alongside ClogP values of amino acids (Fig 6B) .
Interestingly, C5.5 displays a high ClogP value while SC5.5 displays an extremely low ClogP value.
Only when C5.5 is in trinucleotide form does the ClogP value reduce to near zero. ClogP values beyond trinucleotide form could not be predicted due to the increased number of atoms and software limitations. However, we expect as more nucleotides are added (54 in one 3WJ nanoparticle), the ClogP value would drastically decrease.
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CONCLUSIONS
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